
doi: 10.1007/bf00302721
pmid: 6349581
Toxicological studies in a variety of different animal species have shown that cyclosporin A (CS-A) is a unique immunosuppressant, since it does not cause myelotoxic, teratogenic, mutagenic, or carcinogenic effects. This is undoubtedly due to the fact CS-A produces its immunosuppressive effects by a specific action on T lymphocytes rather than by a cytotoxic mechanism. The incidence of acute inflammatory lesions was also not significantly higher in treated animals than in controls. Clear-cut organ toxicity only occurred in rats and cynomolgus monkeys, where at high doses nephro- and hepatotoxicity were observed.
Male, Skin Neoplasms, Dose-Response Relationship, Drug, Papilloma, Cyclosporins, Neoplasms, Experimental, Kidney Tubular Necrosis, Acute, Gingivitis, Macaca mulatta, Rats, Macaca fascicularis, Mice, Dogs, Pregnancy, Animals, Female, Rabbits, Chemical and Drug Induced Liver Injury, Fetal Death
Male, Skin Neoplasms, Dose-Response Relationship, Drug, Papilloma, Cyclosporins, Neoplasms, Experimental, Kidney Tubular Necrosis, Acute, Gingivitis, Macaca mulatta, Rats, Macaca fascicularis, Mice, Dogs, Pregnancy, Animals, Female, Rabbits, Chemical and Drug Induced Liver Injury, Fetal Death
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 246 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
